lauryl gallate has been researched along with Disease Models, Animal in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chorilli, M; Conçolaro, RS; da Silva, PB; Fusco Almeida, AM; Lourencetti, NMS; Mendes Giannini, MJS; Nazaré, AC; Oliveira, LR; Polaquini, CR; Regasini, LO; Scorzoni, L; Singulani, JL; Victorelli, FD | 1 |
Campbell, KC; Hughes, LF; Larsen, DL; Meech, RP; Rybak, LP | 1 |
2 other study(ies) available for lauryl gallate and Disease Models, Animal
Article | Year |
---|---|
Potential of the association of dodecyl gallate with nanostructured lipid system as a treatment for paracoccidioidomycosis: In vitro and in vivo efficacy and toxicity.
Topics: Animals; Antifungal Agents; Biological Availability; Cell Line; Disease Models, Animal; Female; Fibroblasts; Gallic Acid; Humans; Inhibitory Concentration 50; Lipids; Lung; Male; Mice; Mice, Inbred BALB C; Nanoparticles; Paracoccidioides; Paracoccidioidomycosis; Treatment Outcome; Zebrafish | 2018 |
Glutathione ester but not glutathione protects against cisplatin-induced ototoxicity in a rat model.
Topics: Acoustic Stimulation; Animals; Antineoplastic Agents; Cisplatin; Disease Models, Animal; Evoked Potentials, Auditory, Brain Stem; Gallic Acid; Glutathione; Hair Cells, Auditory, Outer; Hearing Loss; Inactivation, Metabolic; Injections, Intraperitoneal; Rats | 2003 |